DTPM is proud to offer our FDA EUA Authorized DTPM COVID-19 RT-PCR Test for use in your laboratory.

In response to the recent influx of virus cases in the United States, the FDA has issued emergency use guidelines to promote and develop new assays capable of detecting SARS-CoV-2 (COVID-19).

DTPM is proud to provide our novel test for COVID-19 which has achieved FDA emergency use authorization. The assay is available to all of our customers and has been utilized in Tide Laboratories since March 23, 2020.

If you are a lab looking to partner with us and begin Coronavirus testing, please fill out the form on this page. If you are an individual looking for where to get tested, please contact us and we will direct you to one of our partner labs nearest to you.

About DTPM

Collectively, the staff at DTPM have over 26 years of experience setting up laboratories and over 30 years of research experience, and we’ve already developed over 150 molecular assays, four of which detect other strains of the Coronavirus (Coronavirus 229E, Coronavirus HKU1, Coronavirus NL63, Coronavirus OC43).

COVID-19 Variants

The DTPM COVID-19 RT-PCR Test has been tested and verified to detect multiple variants of the SARS-CoV-2 (COVID-19) virus, including the delta and omicron strains. Read the statement from our Director of Laboratory Operations on the full gamut of testing we’ve done with our assay, or learn more about why these variants exist.

Related Articles & Information:

Fact Sheets for the DTPM COVID-19 RT-PCR Test

The following documentation is available from the FDA: